| # | Drug | Count |
|---|---|---|
| 0 | URSODIOL | 81 |
| 1 | URSOSIOL | 77 |
| 2 | LANSOPRAZOLE | 58 |
| 3 | ASFOTASE ALFA | 53 |
| 4 | ACETAMINOPHEN | 48 |
| 5 | OMEPRAZOLE MAGNESIUM | 43 |
| 6 | ALBUTEROL SULFATE | 41 |
| 7 | ERGOCALCIFEROL | 40 |
| 8 | OMEPRAZOLE | 37 |
| 9 | FOLIC ACID | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMIZESTRANT | 1 | 0.0714 |
| 1 | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | 1 | 0.0417 |
| 2 | TELISOTUZUMAB VEDOTIN | 1 | 0.0128 |
| 3 | SELADELPAR LYSINE | 2 | 0.0072 |
| 4 | PRILOCAINE HYDROCHLORIDE | 1 | 0.0062 |
| 5 | FLOXURIDINE | 1 | 0.0058 |
| 6 | ASFOTASE ALFA | 53 | 0.0051 |
| 7 | ABACAVIR AND LAMIVUDINE | 1 | 0.0050 |
| 8 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 9 | URSOSIOL | 77 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 100 |
| 1 | Proton Pump Inhibitor [EPC] | 99 |
| 2 | Bile Acid [EPC] | 81 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 74 |
| 4 | Benzodiazepine [EPC] | 61 |
| 5 | Platinum-based Drug [EPC] | 54 |
| 6 | Azole Antifungal [EPC] | 53 |
| 7 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 53 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 51 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 50 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 27 | 0.0392 |
| 1 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 53 | 0.0051 |
| 2 | Bile Acid [EPC] | 81 | 0.0035 |
| 3 | Provitamin D2 Compound [EPC] | 40 | 0.0013 |
| 4 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 5 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 6 | CD30-directed Immunoconjugate [EPC] | 11 | 0.0011 |
| 7 | Thyroid Hormone Receptor beta Agonist [EPC] | 2 | 0.0009 |
| 8 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 9 | Estrogen Receptor Antagonist [EPC] | 25 | 0.0006 |